First theranostic for warfarin enters US
This article was originally published in Clinica
Executive Summary
The first theranostic test for anticoagulant drug warfarin (trade name Coumadin) has been given the green light by the US FDA. The test, made by Northbrook, Illinois firm Nanosphere, was cleared for sale under the 510(k) regulatory pathway.